1262882-75-6

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1247739-25-8 5-cyclopropyl-2-methylaniline 
• 39478-78-9 5-bromo-2-methylaniline 

Downstream Products

• 1262882-79-0 1-(2-amino-4-cyclopropylphenyl)-3,3-dimethylbutan-2-ol 
• 1262882-78-9 tert-butyl[5-cyclopropyl-2-(2-hydroxy-3,3-dimethylbutyl)phenyl]carbamate 

Relevant academic research and scientific papers

INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF

The present invention provides a compound represented by the general formula (I) of the present invention, which has EP1 receptor antagonism: wherein A represents a benzene ring, a pyridine ring, or the like; Y1 represents a C1-6 alkylene group or the like; Y2 represents a single bond or the like; Z represents —C(═O)—NHSO2R6, an acidic 5-membered hetero ring group, or the like; R1 represents a hydrogen atom or the like; R2 represents a phenyl group, a 5-membered aromatic heterocyclic group, or the like; R3 represents a halogen atom, a C1-6 alkoxy group, or the like; R4 represents a hydrogen atom, a halogen atom, or the like; R5 represents a hydrogen atom or the like; and R6 represents a C1-6 alkyl group or the like], or a pharmaceutically acceptable salt thereof. Furthermore, the compound (I) of the present invention can be used as an agent for treating or preventing LUTS, in particular, various symptoms of OABs.